Animal Health Innovation | Boehringer Ingelheim
Animal Health Global Innovation
Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health. We collaborate with our internal colleagues in human health and with many external partners to deliver breakthrough animal health therapies. We maximize our ability to enhance the wellbeing of animals by focusing on areas that will impact the greatest number of animals.
[Empowering future veterinarians, serving the community](/content/science-innovation/animal-health-innovation/empowering-future-veterinarians-serving-community "Empowering future veterinarians, serving the community"/index.html)
Animal Health Innovation
Empowering future veterinarians, serving the community
Learn how collaboration, trust, and shared goals are making a difference for people and animals and what it means for the next generation of vets.
Read more
[Inspiring Future Leaders in Veterinary Medicine and Research through Our Veterinary Scholars Program](/content/science-innovation/animal-health-innovation/future-leaders-veterinary-medicine-and-research "Future Leaders in Veterinary Medicine and Research"/index.html)
Animal Health Innovation
Inspiring Future Leaders in Veterinary Medicine and Research through Our Veterinary Scholars Program
Learn more about the Boehringer Ingelheim Veterinary Scholars Program and how you can apply.
Read more
[Supporting future veterinarians](/content/science-innovation/animal-health-innovation/boehringer-ingelheim-veterinary-scholars-program "The Boehringer Ingelheim Veterinary Scholars Program"/index.html)
Animal Health Innovation
Supporting future veterinarians
The aim of the Boehringer Ingelheim Veterinary Scholars Program is to expose students to biomedical research.
Read more
Related Press Releases
[Boehringer Ingelheim’s SEMINTRA® 4 mg/ml oral solution now launched for cats with chronic kidney disease and hypertension](/content/science-innovation/animal-health-innovation/semintra-4mg-ml-oral-solution-cats-chronic-kidney-disease-hypertension "SEMINTRA 4mg/ml oral solution cats chronic kidney disease hypertension"/index.html)
February 12, 2025
Boehringer Ingelheim’s SEMINTRA® 4 mg/ml oral solution now launched for cats with chronic kidney disease and hypertension
[Read more](/content/science-innovation/animal-health-innovation/semintra-4mg-ml-oral-solution-cats-chronic-kidney-disease-hypertension "Read more about "Boehringer Ingelheim’s SEMINTRA® 4 mg/ml oral solution now launched for cats with chronic kidney disease and hypertension""/index.html)
[Boehringer Ingelheim launches EURICAN® L4 vaccine, offering outstanding protection against leptospirosis in dogs](/content/science-innovation/animal-health-innovation/vaccine-protection-leptospirosis-dogs "vaccine protection leptospirosis in dogs"/index.html)
November 28, 2024
Boehringer Ingelheim launches EURICAN® L4 vaccine, offering outstanding protection against leptospirosis in dogs
[Read more](/content/science-innovation/animal-health-innovation/vaccine-protection-leptospirosis-dogs "Read more about "Boehringer Ingelheim launches EURICAN® L4 vaccine, offering outstanding protection against leptospirosis in dogs""/index.html)